# Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study

> **NCT06078722** · — · UNKNOWN · sponsor: **Kazakh Association of Internal Medicine Specialists** · enrollment: 264 (estimated)

## Conditions studied

- Metabolic-associated Fatty Liver Disease (MAFLD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06078722
- **Lead sponsor:** Kazakh Association of Internal Medicine Specialists
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-08
- **Primary completion:** 2025-02-08
- **Final completion:** 2025-02-08
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06078722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06078722, "Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06078722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*